Cytostatics are widely used in a variety of oncological treatments. Through such agents, we can accomplish the following:
- Destroy cancer tumors,
- Improve surgical or radiotherapeutic outcomes,
- Reduce the size of metastases, and
- Alleviate cancer symptoms.
Cytostatics damage cells so that the cells are unable to divide and therefore die. Cytostatics affect all dividing cells, including healthy ones.
In comparison with normal cells, cancer cells often divide substantially faster, which makes cancer cells particularly sensitive to cytostatics. The impact of cytostatics on healthy cells is lower and the recovery of healthy cells is faster as well. When chemotherapy is repeated at certain intervals, the cancerous tissue will not have time to recover between treatments. By contrast, the healthy tissues will recover. Thus, the number of cancer cells is reduced every time.
Cytostatics are carried by the circulation throughout the system. Thus, they can also destroy small cancerous tumors that may have gone undetected by the examinations.
For cancer treatment, we use a number of cytostatics, which together have a variety of effects. Most commonly, we give combination therapy involving several different cytostatic drugs. For the attainment of a successful outcome, the treatment is dictated on an individual basis.
The duration of chemotherapy, the frequency of the courses of treatment, as well as the cytostatic drugs administered, are all planned and conducted on an individual basis, taking into account the degree of metastasis.
Cytostatics can be administered orally as tablets or intravenously on a drip. We provide intravenous treatment on an outpatient basis. After being on the drip, the patient is free to go home. Sometimes the drug is administered locally, for example, to the pleura, the bladder, or the spinal canal.
Usually, the courses of treatment are given at intervals of three to four weeks. However, some treatments are administered more frequently: even on a weekly basis. Each drug has a means of administration that has been shown safe by experience. The treatment times vary from half an hour to a few hours at a time.
Typical Adverse Effects of Cytostatics
Cytostatics do not distinguish cancer cells from healthy, fast-growing, normal cells. Because cytostatics affect dividing cells, many of the adverse effects focus on rapidly regenerating tissues, such as hair, bone marrow, and mucous membranes.
The quality and magnitude of the effects depend on the pharmaceutical substances used, the doses, the general condition of the patient, and the bodily reaction to the medication. Due to this, the adverse effects will vary from one patient to another. Nowadays, most of these effects can be effectively prevented or treated.
Typical adverse effects include the following:
- Low blood counts,
- Hair loss,
- Abdominal and intestinal issues,
- Fatigue, and
Cytostatic chemotherapy demands close hematological monitoring. Despite the adverse effects, the patient’s ability to function during the treatment period will be good for the most part.
Some of the adverse effects will pass in a few days. Recovery from cytostatic chemotherapy generally takes a few months. Luckily, adverse effects of a more prolonged nature are rare.
Our Range of Specialization
Some examples of our areas of specialization in the field of cytostatic chemotherapy include treatments for breast cancer and urological cancers, such as prostate cancer, bladder cancer, and renal cancer. Additionally, we plan and carry out chemotherapies for lung cancer, as well as cytostatic treatments for abdominal cancers, such as the cancers of the liver, the pancreas, the stomach, and the intestines.
Cytostatic treatment is planned on an individual basis. Based on this, the patient then receives a quotation for the treatment.
How to Get Your Examinations and Treatment
Ask about treatment or make an appointment by contacting the Customer Service of the HYKSin Ltd private hospital via telephone, Secured e-mail, or online bookings. Please see our contact information here.
We provide treatment for patients over the age of 16.